European Commission's Scientific Committee is asking for ophthalmic experts' help

Article

The European Commission's independent Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) is seeking the assistance of ophthalmic experts who are interested in helping with its Health Effects Of Artificial Light working group.

The European Commission's independent Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) is seeking the assistance of ophthalmic experts who are interested in helping with its Health Effects Of Artificial Light working group.

The SCENIHR would specifically like to hear from ophthalmologists who have experience and knowledge of eye damage that has been induced by optical radiation. Additional knowledge of either retinal or cataract damage would also prove useful. Candidates with risk assessment experience would also be advantageous.

The deadline for applications is 1st September 2010 and instructions for submitting an application can be found here.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.